![Max Sonnleitner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Max Sonnleitner is currently a Co-Managing Director at GENSPEED Biotech GmbH.
Max Sonnleitner active positions
Companies | Position | Start |
---|---|---|
GENSPEED Biotech GmbH
![]() GENSPEED Biotech GmbH BiotechnologyHealth Technology GENSPEED Biotech GmbH develops, produces, and distributes testing solutions based on the patented Genspeed technology. It offer GENSPEED HAI, a product line for the rapid detection of the most common nosocomial pathogens and their resistances, PerioPOC, an assay for the differential diagnostics within the dental office for an individual therapeutic approach and efficient monitoring, GENSPEED, a universal Point of Care Testing technology for assay manufacturers who aim for a maximum benefit through fast and reliable near-patient testing. The company was founded in 2016 and is headquartered in Rainbach, Austria. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
GENSPEED Biotech GmbH
![]() GENSPEED Biotech GmbH BiotechnologyHealth Technology GENSPEED Biotech GmbH develops, produces, and distributes testing solutions based on the patented Genspeed technology. It offer GENSPEED HAI, a product line for the rapid detection of the most common nosocomial pathogens and their resistances, PerioPOC, an assay for the differential diagnostics within the dental office for an individual therapeutic approach and efficient monitoring, GENSPEED, a universal Point of Care Testing technology for assay manufacturers who aim for a maximum benefit through fast and reliable near-patient testing. The company was founded in 2016 and is headquartered in Rainbach, Austria. | Health Technology |
- Stock Market
- Insiders
- Max Sonnleitner